Founded in 2004, Partner Fund Management stands as a prominent healthcare investment advisor known for managing both public and private investments within the sector. The firm has built a reputation for its expertise in navigating the complexities of healthcare markets, offering strategic guidance and investment solutions tailored to the evolving needs of its clients.
Christopher Medlock James has served as the President of Partner Fund Management, L.P. since August 1, 2004, bringing over two decades of leadership and expertise to the role. Christopher Medlock James's tenure has been marked by a commitment to excellence, driving strategic initiatives that have enhanced the firm's capabilities and expanded its presence in global markets.
Partner Fund Management operates as a hedge fund managing discretionary assets totaling $2,429,746,663, based on their Form ADV filed on March 2024. The firm serves 8 clients, with their latest 13F filing for Q1 2024 disclosing $2,127,260,197 in managed 13F securities and a top 10 holdings concentration of 40.03%. PFM Health Sciences's largest holding is in Eli Lilly & Co., with 298,643 shares held.
| Fund Name: | Partner Fund Management |
| Manager | Christopher Medlock James |
| Portfolio Value | $2,020,765,412 |
| Change This QTR | +0.95% |
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | LLY | 298,643 | $270,385,399 | 13.38% | |||
| 2. | CYTK | 1,757,192 | $95,204,663 | 4.71% | |||
| 3. | Invesco Qqq TrCALLCALL | 187,400 | $89,785,214 | NEW | 4.44% | ||
| 4. | THC | 589,409 | $78,409,079 | 3.88% | |||
| 5. | MRK | 596,261 | $73,817,112 | 3.65% |
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2024-02-14 | ||||
| 2024-02-14 | ||||
| 2024-02-14 | ||||
| 2024-02-14 | ||||
| 2024-02-14 |
